14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.71 Thursday, 25th Apr 2024 CANF stock ended at $1.92. This is 1.03% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.62% from a day low at $1.92 to a day high of $1.97.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Apr 25, 2024 $1.94 $1.97 $1.92 $1.92 9 591
Apr 24, 2024 $1.96 $1.96 $1.94 $1.94 5 741
Apr 23, 2024 $1.96 $1.98 $1.96 $1.97 3 656
Apr 22, 2024 $2.00 $2.04 $1.91 $1.98 8 684
Apr 19, 2024 $1.96 $2.03 $1.96 $1.98 7 816
Apr 18, 2024 $2.00 $2.07 $1.97 $1.97 10 456
Apr 17, 2024 $2.10 $2.10 $1.95 $1.96 31 901
Apr 16, 2024 $2.07 $2.29 $2.07 $2.08 13 145
Apr 15, 2024 $2.20 $2.21 $2.02 $2.07 20 092
Apr 12, 2024 $2.32 $2.34 $2.10 $2.10 14 149
Apr 11, 2024 $2.31 $2.32 $2.20 $2.28 11 672
Apr 10, 2024 $2.21 $2.42 $2.21 $2.35 11 769
Apr 09, 2024 $2.38 $2.50 $2.26 $2.26 20 911
Apr 08, 2024 $2.44 $2.46 $2.30 $2.40 9 801
Apr 05, 2024 $2.35 $2.54 $2.25 $2.35 38 984
Apr 04, 2024 $2.29 $2.43 $2.20 $2.33 32 290
Apr 03, 2024 $2.30 $2.32 $2.21 $2.29 5 112
Apr 02, 2024 $2.40 $2.40 $2.06 $2.25 25 637
Apr 01, 2024 $2.29 $2.71 $2.24 $2.31 74 844
Mar 28, 2024 $2.29 $2.29 $2.22 $2.22 7 206
Mar 27, 2024 $2.23 $2.26 $2.21 $2.26 11 263
Mar 26, 2024 $2.24 $2.26 $2.18 $2.18 7 935
Mar 25, 2024 $2.23 $2.24 $2.18 $2.19 19 009
Mar 22, 2024 $2.19 $2.23 $2.12 $2.23 17 661
Mar 21, 2024 $2.22 $2.23 $2.19 $2.19 15 565
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT